A Vanderbilt-Ingram Cancer Center lung cancer specialist will participate in an “Ask the Expert” teleconference on Monday, Nov. 12, as part of National Lung Cancer Awareness Month activities.
The topic is “Cancer Clinical Trials: Weighing the Options.” The event is free, but participants must register.
Betty Layne of the Alliance for Lung Cancer Advocacy, Support and Education (ALCASE) will join Dr. Alan Sandler, director of the Vanderbilt-Ingram Cancer Center’s thoracic oncology program, in the teleconference, which will run 1-2 p.m. Together, they will share information and answer questions about how patients can find clinical studies and work with their doctors to find one that is right for them.
Lung cancer is the leading cancer killer of both men and women in the United States, claiming more than 157,000 each year. About 170,000 new cases are diagnosed each year.
While smoking is the most important risk factor for lung cancer, one in six cases of the deadly disease are diagnosed in non-smokers. Half of new cases occur in former smokers.
Registration deadline is Nov. 9. To register and for more information, call ALCASE toll-free at 1-800-298-2436.
For information about clinical trials at Vanderbilt-Ingram, visit www.vicc.org or call 1-800-811-8480.